Pfizer profit up on third quarter Covid treatment sales
Pfizer has today reported higher-than-expected third quarter profit due to strong sales of Covid-19 treatment Paxlovid, an important win for chief executive Albert Bourla as he faces down activist investor Starboard.
Business
• 29 Oct 24
